161 related articles for article (PubMed ID: 15003660)
1. Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy.
Finstad CL; Wang CY; Kowalski J; Zhang M; Li ML; Li XM; Xia WG; Bosland MC; Murthy KK; Walfield AM; Koff WC; Zamb TJ
Vaccine; 2004 Mar; 22(9-10):1300-13. PubMed ID: 15003660
[TBL] [Abstract][Full Text] [Related]
2. Totally synthetic peptide-based immunocontraceptive vaccines show activity in dogs of different breeds.
Walker J; Ghosh S; Pagnon J; Colantoni C; Newbold A; Zeng W; Jackson DC
Vaccine; 2007 Oct; 25(41):7111-9. PubMed ID: 17825958
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of prostate cancer in a murine model using a novel GnRH based vaccine candidate.
Junco JA; Peschke P; Zuna I; Ehemann V; Fuentes F; Bover E; Pimentel E; Basulto R; Reyes O; Calzada L; Castro MD; Arteaga N; López Y; Garay H; Hernández H; Bringas R; Guillén GE
Vaccine; 2007 Dec; 25(50):8460-8. PubMed ID: 18022737
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal microSPECt/CT imaging and pharmacokinetics of synthetic luteinizing hormone-releasing hormone (LHRH) vaccine in rats.
Chang CH; Hsu WC; Wang CY; Jan ML; Tsai TH; Lee TW; Lynn SG; Yeh CH; Chang TJ
Anticancer Res; 2007; 27(5A):3251-8. PubMed ID: 17970068
[TBL] [Abstract][Full Text] [Related]
5. A recombinant luteinising-hormone-releasing-hormone immunogen bioeffective in causing prostatic atrophy.
Talwar GP; Raina K; Gupta JC; Ray R; Wadhwa S; Ali MM
Vaccine; 2004 Sep; 22(27-28):3713-21. PubMed ID: 15315851
[TBL] [Abstract][Full Text] [Related]
6. Site-specific peptide vaccines for immunotherapy and immunization against chronic diseases, cancer, infectious diseases, and for veterinary applications.
Wang CY; Walfield AM
Vaccine; 2005 Mar; 23(17-18):2049-56. PubMed ID: 15755569
[TBL] [Abstract][Full Text] [Related]
7. Effect of active immunization against luteinizing hormone-releasing hormone on the androgen-sensitive Dunning R3327-PAP and androgen-independent Dunning R3327-AT2.1 prostate cancer sublines.
Fuerst J; Fiebiger E; Jungwirth A; Mack D; Talwar PG; Frick J; Rovan E
Prostate; 1997 Jul; 32(2):77-84. PubMed ID: 9215394
[TBL] [Abstract][Full Text] [Related]
8. The C-terminal pentapeptide of LHRH is a dominant B cell epitope with antigenic and biological function.
Zeng W; Pagnon J; Jackson DC
Mol Immunol; 2007 Jul; 44(15):3724-31. PubMed ID: 17512595
[TBL] [Abstract][Full Text] [Related]
9. Gonadotrophin releasing hormone-based vaccine, an effective candidate for prostate cancer and other hormone-sensitive neoplasms.
Junco JA; Basalto R; Fuentes F; Bover E; Reyes O; Pimentel E; Calzada L; Castro MD; Arteaga N; López Y; Hernández H; Bringas R; Garay H; Peschke P; Bertot J; Guillén G
Adv Exp Med Biol; 2008; 617():581-7. PubMed ID: 18497085
[TBL] [Abstract][Full Text] [Related]
10. Identification of dominant epitopes of synthetic immunocontraceptive vaccines that induce antibodies in dogs.
Yu M; Zeng W; Pagnon J; Walker J; Ghosh S; Wang LF; Jackson DC
Vaccine; 2005 Aug; 23(37):4589-97. PubMed ID: 15927323
[TBL] [Abstract][Full Text] [Related]
11. Individual variation of hormonal recovery after cessation of luteinizing hormone-releasing hormone agonist therapy in men receiving long-term medical castration therapy for prostate cancer.
Kobayashi T; Nishizawa K; Mitsumori K
Scand J Urol Nephrol; 2006; 40(3):198-203. PubMed ID: 16809259
[TBL] [Abstract][Full Text] [Related]
12. Strong humoral response elicited by a DNA vaccine targeting gastrin-releasing peptide with optimized adjuvants inhibits murine prostate carcinoma growth in vivo.
Lu Y; Mekoo DJ; Ouyang K; Hu X; Liu Y; Lin M; Jin L; Cao R; Li T; Zhang Y; Fan H; Liu J
Endocr Relat Cancer; 2009 Dec; 16(4):1171-84. PubMed ID: 19648182
[TBL] [Abstract][Full Text] [Related]
13. Active component of a GnRH based vaccine binds to natural GnRH receptors in Dunning R3327-G cell line and human prostate carcinoma vesicles.
Bover Fuentes E; Fuentes Aguilar F; Junco Barranco J; Zaldivar Merino I; Arteaga Moré N; Calzada Aguilera L; López Sáez Y; Pimentel Vázquez E; Basulto Baker R
J Exp Ther Oncol; 2007; 6(4):279-84. PubMed ID: 18038761
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in contraceptive vaccine development: a mini-review.
Naz RK; Gupta SK; Gupta JC; Vyas HK; Talwar AG
Hum Reprod; 2005 Dec; 20(12):3271-83. PubMed ID: 16113040
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of human experimental prostate cancers by a targeted cytotoxic luteinizing hormone-releasing hormone analog AN-207.
Stangelberger A; Schally AV; Nagy A; Szepeshazi K; Kanashiro CA; Halmos G
Prostate; 2006 Feb; 66(2):200-10. PubMed ID: 16173040
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of an anti-fertility vaccine based on mammalian gonadotrophin releasing hormone (GnRH-I)--a histological comparison in male animals.
Ferro VA; Khan MA; McAdam D; Colston A; Aughey E; Mullen AB; Waterston MM; Harvey MJ
Vet Immunol Immunopathol; 2004 Sep; 101(1-2):73-86. PubMed ID: 15261694
[TBL] [Abstract][Full Text] [Related]
17. Evidence that prostate gonadotropin-releasing hormone receptors mediate an anti-tumourigenic response to analogue therapy in hormone refractory prostate cancer.
Gnanapragasam VJ; Darby S; Khan MM; Lock WG; Robson CN; Leung HY
J Pathol; 2005 Jun; 206(2):205-13. PubMed ID: 15818594
[TBL] [Abstract][Full Text] [Related]
18. Bypass of carrier-induced epitope-specific suppression using a T-helper epitope.
Sad S; Rao K; Arora R; Talwar GP; Raghupathy R
Immunology; 1992 Aug; 76(4):599-603. PubMed ID: 1383134
[TBL] [Abstract][Full Text] [Related]
19. Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope.
Lu Y; Ouyang K; Fang J; Zhang H; Wu G; Ma Y; Zhang Y; Hu X; Jin L; Cao R; Fan H; Li T; Liu J
Vaccine; 2009 Aug; 27(39):5411-8. PubMed ID: 19616501
[TBL] [Abstract][Full Text] [Related]
20. [Effect of LHRH crasis protein as vaccine on the reproductive function of male rats].
Cai R; Pan Q; Pan Y; Jia Y; Ma D; Wang X; Cui Y
Zhonghua Nan Ke Xue; 2004 Jun; 10(6):426-8. PubMed ID: 15267205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
